Broader Metabolic Benefits: Targeting two key incretin pathways may offer broader benefits for glucose control and energy expenditure
Indications and Usage Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg and Ozempic (semaglutide) tablets 4 mg or 9 mg are indicated: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes Ozempic injection is indicated: to reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes and established CV disease to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease Ozempic tablets are indicated: to reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes who are at high risk for these events Important Safety Information for Ozempic WARNING: RISK OF THYROID C-CELL TUMORS In rodents, semaglutide causes dose-dependent and treatment-duration- dependent thyroid C-cell tumors at clinically relevant exposures
C., Montillo, A
Particular attention is needed for insulin and sulfonylureas (hypoglycemia risk), oral contraceptives (reduced absorption), thyroid medications (altered absorption timing), and blood thinners (variable absorption)
The progression is not simply "more of the same" each receptor system addresses different aspects of metabolic physiology, and their interactions produce emergent effects that cannot be predicted from the individual receptor pharmacology alone
Aetna only covers Wegovy for indications approved by the Food and Drug Administration (FDA)
